This review explores how chitosan nanoparticles enhance drug delivery of plant extracts, suggesting a sustainable approach for herbal therapies.
Chitosan Nanoparticles (CHNPs) have emerged as a promising nanocarrier system for the delivery of medicinal plant extracts, owing to their biodegradability, biocompatibility, and mucoadhesive properties. This review outlines the eco-friendly synthesis approaches of CHNPs and their role in enhancing the pharmacokinetic and pharmacodynamic profiles of plant-derived bioactives. Encapsulation of phytoconstituents in CHNPs significantly improves their solubility, stability, and bioavailability, and enables site-specific, controlled drug release. Plant-extract-loaded CHNPs have demonstrated broad-spectrum pharmacological activities, including antioxidant, anti-inflammatory, antimicrobial, antitumor, hepatoprotective, and immunomodulatory effects. Additionally, CHNPs are being explored for wound healing, vaccine delivery, and cancer therapeutics. Despite certain formulation and scalability challenges, CHNPs represent a sustainable and versatile strategy for herbal drug delivery. Future perspectives focus on advanced functionalization and clinical translation, integrating traditional phytotherapy with modern nanomedicine.
No takes yet. Share an insight, caveat, or question.
Jana et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: